Current Opportunities

The Colorectal Pathway Board is a multi-disciplinary team of varied clinical and non-clinical members that has a responsibility to improve cancer care for patients on the Greater Manchester colorectal pathway.

The Pathway Board representative represents the collective views of local patients with cancer, and carers at the Pathway Board meetings by identifying appropriate areas for contribution.

For more information, please take a look at the role profile below.

Colorectal Pathway Board Patient and Carer Representative – Role Profile Nov 24

You will be provided with application information to read ahead of the interviews. On the day of the interviews, there will be a presentation by the candidates, followed by questions. You will follow guidance from the lead interviewer (Susan Todd) about how to score, and a brief catch up prior to the interviews will be offered if required.

1. 1. 1. 1. Head and Neck Cancer Clinical Lead, 11/2/25 1330 – 1630
         2. Haematological Cancer Clinical Lead, 17/2/25 1500 – 1715
         3. Research Clinical Lead date/time tbc (Feb or March, 2.5 hours max)

Cancer Board takes place one every two months, and reports to the whole NHS in Greater Manchester. The board reports on progress, performance, national and regional deliverables and items including finance, strategy and risk. It brings together senior representatives covering the whole patient pathway who should make decisions on behalf of their organisations, and contribute actively to leading delivery of the Cancer Alliance Plan.

To find out more about this role, please read the role profile or contact us for an informal chat.

Cancer Board Patient and Carer Representative

Alongside that, we would need some help to design a new patient information leaflet for a new lung clinic. To ensure the leaflet is clear, uses plain English and includes all the information you think a patient might need to know.

Lung Pathway Board Patient and Carer Representative

Our primary objectives are: Reducing Time to diagnosis, Achieve National Cancer Targets, Streamlining Referral-to-Treatment Pathways and Improving Patient Experience. As a representative, you will work alongside another representative to ensure that the voices of patients and carers are heard and considered in the board’s decisions. Through these efforts, we seek to ensure that cancer patients in GM receive the best possible care with minimal delays, aligning with the broader national strategy for cancer care excellence.

Role Profile – FDS OP TV

They are looking to recruit an inclusive panel that represents a breadth of experiences, identities and communities including:

– Anyone with lived experience of any gynae cancer (with or without experience of radiotherapy)
– Anyone who has cared for someone with any gynae cancer (with or without experience of radiotherapy)
– Anyone who could go on to develop a gynae cancer (and therefore might be referred for radiotherapy)

Panel members can get involved in a variety of activities including:
• designing research activities such as focus groups and workshops
• helping to promote the research at events
• carrying out interviews and interpreting the data with the team
• attending steering groups and meetings

This poster contains more information, including how to apply.

Earlier and faster diagnosis of cancer is dependent on people understanding and being aware of the early signs and symptoms of cancer, by taking up screening programmes or visiting a healthcare professional. Healthcare professionals must also be aware of and have the tools to hand to ensure a timely referral.

A programme of work has been established on behalf of GM Cancer Alliance and the GM system to support the delivery of the NHS Long Term Plan early cancer diagnosis ambition.

For more information about this opportunity, please read the role profile.

The urology pathway board is a multi-disciplinary team of varied clinical and non-clinical members that focusses on the development and improvement of urological cancer services across Greater Manchester.

The role of the Patient and Carer Representatives is to represent and communicate what matters to patients and carers within the urology cancer pathway. The urology small community meetings are designed to support this, alongside any additional external support groups/meetings.

For more information, please take a look at the role profile.

If you are interested or want to find out more, please contact us by clicking ‘enquire about opportunity’.

Specific Opportunities November 2024 – Jan 2025

• Helping to develop and champion World Cancer Day 2025 @ Manchester Cancer Research Centre (4^th Feb 2025)
• Radiotherapy projects working with animals – help to test new ideas around efficacy and learn lessons from radiotherapy treatment pathways

If you are interested in any of the above, please get in contact with simon.reeds@manchester.ac.uk for a discussion or more details.

A small community can be defined as an ‘expert by experience’ focus group, where members share lived experience of a particular cancer type/pathway, and help us to make improvements.

We are looking to expand our small communities to ensure we hear from a diverse range of patient and carer viewpoints, and are particularly interested in those who have been diagnosed or affected by cancer recently.

For more information on small communities, and experience/skills required, please read our terms of reference and our role profile